title: [Frontal atypical teratoid/rhabdoid tumor evaluated by single-photon emission computerized tomography and positron emission tomography].
abstract: A case of frontal atypical teratoid/rhabdoid tumor (AT/RT) was presented in the findings of single-photon emission computerized tomography (SPECT) using 201Tl-chloride (Tl) and 123I-metaiodobenzylguanidine (MIBG), and positron emission tomography using 18F-fluorodeoxyglucose (FDG) and (11C-methyl)-L-methionine (Met). A 16-year-old female had an episode of Jacksonian seizures one month prior to admission. CT scans showed an isodensity mass with heterogeneous enhancement in the left frontal lobe. MR images revealed a tumor with solid and cystic components and perifocal edema. SPECT demonstrated intense accumulation of Tl and MIBG in the enhancing lesion 15 min and 30 min after intravenous injection of tracers, respectively. The 6-hr delayed SPECT showed no retention of MIBG in the enhancing lesion. FDG-PET and Met-PET revealed high uptake of tracers in the enhancing lesion. Met did not accumulate in the frontal white matter, which appeared hyperintense on T2-weighted MR images. The patient underwent an uneventful extirpation of the solid mass, where Met had accumulated. Microscopically, the solid tumor contained rhabdoid cells, spindle-shaped cells resembling mesenchymal cells, and nests of small cells. The tumor cells were immunoreactive for vimentin, cytokeratin, and epithelial membrane antigen. The MIB-1 labeling index was 25%. The histological diagnosis was AT/RT. Postoperative course was uneventful. A dose of 32.4 Gy was administrated to the whole brain and a boost of 27.8 Gy to the T2-hyperintensity lesion. Five months after the radiotherapy, MRI showed neither abnormal enhancing lesions nor the T2-hyperintensity lesion. Multifarious studies using SPECT and PET are useful for differential diagnosis and for choosing optimal therapeutic strategy for this type of tumor.
authors.affiliation: Department of Neurosurgery, Akita University School of Medicine, 1-1-1 Hondo, Akita-city, Akita 010-8543, Japan.
authors.forename: Toshio
authors.initials: T
authors.lastname: Sasajima
authors.forename: Masaya
authors.initials: M
authors.lastname: Oda
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kinouchi
authors.forename: Jun
authors.initials: J
authors.lastname: Hatazawa
authors.forename: Kazuo
authors.initials: K
authors.lastname: Mizoi
mesh_terms: D019797:3-Iodobenzylguanidine; D000293:Adolescent; D001932:Brain Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D019275:Radiopharmaceuticals; D018335:Rhabdoid Tumor / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D013724:Teratoma / Q000175:diagnosis / Q000473:pathology / Q000601:surgery*; D013793:Thallium; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; C027549:thallium chloride; D013793:Thallium